Agilent Technologies CEO Padraig McDonnell Reports Strong Q3 2025 Results Driven by Ignite Transformation and Broad-Based Growth

Agilent CEO Padraig McDonnell announces Q3 2025 revenue of $1.74 billion, marking fifth straight quarter of core growth under Ignite Transformation.

The company reported revenue of $1.74 billion, exceeding its guidance range and reflecting 10.1% reported growth and 6.1% core growth compared with the third quarter of 2024. This marks the fifth consecutive quarter of sequential core-revenue acceleration, highlighting Agilent’s continued momentum under its Ignite Transformation strategy.

CEO Commentary

“Our third-quarter performance, which marks our fifth consecutive quarter of sequential core-revenue acceleration, is a testament to the success of our Ignite Transformation and our laser-like focus on profitable growth and operational excellence,” said Padraig McDonnell, President and Chief Executive Officer of Agilent Technologies. “All three of our business groups grew, along with all regions and our two largest markets. Our Ignite enterprise operating model enables us to nimbly and quickly navigate a highly dynamic macro environment while remaining focused on our strong execution, innovation pipeline, and deep customer relationships.”

Financial Performance Highlights

• Revenue: $1.74 billion, up 10.1% reported and 6.1% core year-over-year

• GAAP Net Income: $336 million, or $1.18 per share, compared with $282 million, or $0.97 per share in Q3 2024

• Non-GAAP Net Income: $390 million, or $1.37 per share, compared with $385 million, or $1.32 per share last year

Agilent’s strong quarterly performance was driven by broad-based demand across its Life Sciences, CrossLab, and Applied Markets business groups, supported by continued strength in its core markets and efficient execution across regions.

Segment Results

Life Sciences and Diagnostics Markets Group (LDG)

• Revenue: $670 million

• Growth: +14% reported, +7% core year-over-year

• Operating Margin: 17.6%
  LDG achieved robust growth fueled by demand for advanced analytical and diagnostic solutions, reflecting strong performance in both developed and emerging markets.

Agilent CrossLab Group (ACG)

• Revenue: $744 million

• Growth: +8% reported, +5% core year-over-year

• Operating Margin: 33.3%
  ACG continued to expand its recurring revenue base through customer service contracts and consumables, reinforcing Agilent’s long-term relationships with global clients.

Applied Markets Group (AMG)

• Revenue: $324 million

• Growth: +7% reported, +5% core year-over-year

• Operating Margin: 21.8%
  AMG benefited from steady demand in the environmental, energy, and food testing markets, underscoring Agilent’s diverse portfolio and resilient business model.

• Outlook for Fiscal Year 2025 and Fourth Quarter

  Agilent has updated its financial outlook for fiscal year 2025 based on its strong performance and operational discipline:

  • Full-Year Revenue: $6.91 billion – $6.93 billion (up 6.2%–6.5% reported; 4.3%–4.6% core)

  • Full-Year Non-GAAP EPS: $5.56 – $5.59

  For the fourth quarter of 2025, Agilent expects:

  • Revenue: $1.822 billion – $1.842 billion (up 7.1%–8.3% reported; 4.8%–6.0% core)

  • Non-GAAP EPS: $1.57 – $1.60

• Commitment to Innovation and Growth

  Under McDonnell’s leadership, Agilent continues to strengthen its innovation pipeline, driving advances across life sciences, diagnostics, and applied markets. The Ignite Transformation initiative has positioned the company to deliver consistent growth through operational excellence, digital transformation, and sustainability-driven strategies.

  “Looking ahead, we remain focused on delivering value to our shareholders while advancing technologies that empower scientists and improve global health outcomes,” added McDonnell.